General Information of the Compound
Compound ID
CP0143387
Compound Name
US9133148, 9aq
    Show/Hide
Synonyms
ABX-1431
BDBM180052
CHEMBL3945728
SCHEMBL15100632
SQZJGTOZFRNWCX-UHFFFAOYSA-N
US9133148, 9aq
    Show/Hide
Structure
Formula
C20H22F9N3O2
Molecular Weight
507.397
Canonical SMILES
FC(F)(F)C(OC(=O)N1CCN(Cc2ccc(cc2N2CCCC2)C(F)(F)F)CC1)C(F)(F)F
    Show/Hide
InChI
InChI=1S/C20H22F9N3O2/c21-18(22,23)14-4-3-13(15(11-14)31-5-1-2-6-31)12-30-7-9-32(10-8-30)17(33)34-16(19(24,25)26)20(27,28)29/h3-4,11,16H,1-2,5-10,12H2
    Show/Hide
InChIKey
SQZJGTOZFRNWCX-UHFFFAOYSA-N
CAS
1446817-84-0
Physicochemical Property
logP
5.053
Rotatable Bonds
4
Heavy Atom Count
34
Polar Areas
36.02
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Complexity
34

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71657619
ChEMBL ID
CHEMBL3945728
DrugBank ID
DB16036
Clinical Information about the Compound
Drug 1 ( ABX-1431 )
Drug Name ABX-1431
Company Abide Therapeutics San Diego, CA
Indication
Neuropathic pain
Phase 1
Tourette syndrome
Phase 1
Target(s)
Monoglyceride lipase (MAGL)
Inhibitor